144 related articles for article (PubMed ID: 24972189)
1. Src as a novel therapeutic target for endometriosis.
Lawrenson K; Lee N; Torres HA; Lee JM; Brueggmann D; Rao PN; Noushmehr H; Gayther SA
Gynecol Oncol; 2014 Oct; 135(1):100-7. PubMed ID: 24972189
[TBL] [Abstract][Full Text] [Related]
2. Novel three-dimensional in vitro models of ovarian endometriosis.
Brueggmann D; Templeman C; Starzinski-Powitz A; Rao NP; Gayther SA; Lawrenson K
J Ovarian Res; 2014 Feb; 7():17. PubMed ID: 24502583
[TBL] [Abstract][Full Text] [Related]
3. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
4. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
5. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
6. [The malignant potential of ovarian atypical endometriosis].
Guo L; Liu T; Lang J
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
[TBL] [Abstract][Full Text] [Related]
7. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
[TBL] [Abstract][Full Text] [Related]
9. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
Lakshminarasimhan R; Andreu-Vieyra C; Lawrenson K; Duymich CE; Gayther SA; Liang G; Jones PA
Cancer Lett; 2017 Aug; 401():11-19. PubMed ID: 28483516
[TBL] [Abstract][Full Text] [Related]
11. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology.
Guo SW
Hum Reprod Update; 2020 Apr; 26(3):423-449. PubMed ID: 32154564
[TBL] [Abstract][Full Text] [Related]
13. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Huang X; Elishaev E; Budiu RA; Zhang L; Kim S; Donnellan N; Mantia-Smaldone G; Ma T; Tseng G; Lee T; Mansuria S; Edwards RP; Vlad AM
Clin Cancer Res; 2014 Dec; 20(23):6163-74. PubMed ID: 25294912
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian cancers complicated by endometriosis].
Obata K; Koike H; Shiina M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():615-22. PubMed ID: 15535319
[No Abstract] [Full Text] [Related]
15. Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
Ono YJ; Terai Y; Tanabe A; Hayashi A; Hayashi M; Yamashita Y; Kyo S; Ohmichi M
J Endocrinol; 2014 Nov; 223(2):203-16. PubMed ID: 25244916
[TBL] [Abstract][Full Text] [Related]
16. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of ovarian endometriosis.
Nishida M; Watanabe K; Sato N; Ichikawa Y
Gynecol Obstet Invest; 2000; 50 Suppl 1():18-25. PubMed ID: 11093057
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Bioinformatics Study on Genes and micro-RNAs Involving the Transformation of Endometriosis into Ovarian Cancer.
Sheikhvatan M; Chaichian S; Moazzami B
Microrna; 2020; 9(2):101-111. PubMed ID: 31530272
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.
Wei JJ; William J; Bulun S
Int J Gynecol Pathol; 2011 Nov; 30(6):553-68. PubMed ID: 21979592
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with ovarian endometriosis malignancy and its recurrence in Chinese women.
Zhang Y; Qu P
J Obstet Gynaecol; 2019 Nov; 39(8):1148-1153. PubMed ID: 31307261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
